Quantcast

Latest Tyrosine kinase inhibitors Stories

2010-04-21 05:00:00

CHICAGO, April 21 /PRNewswire/ -- A clinical study underway at Rex Cancer Center of Wakefield will evaluate the use of telemonitoring in managing administration of Gleevec, a drug developed and manufactured by Novartis to treat chronic myeloid leukemia.

2010-04-19 09:37:00

BROOMFIELD, Colo., April 19 /PRNewswire/ -- Biodesix today announced that results from the VeriStrat biomarker analysis of a Phase III clinical trial will be presented by David Carbone, M.D., Ph.D., Professor of Medicine and Cancer Biology, Vanderbilt University School of Medicine, on Friday, April 30th at the 2nd European Lung Cancer Conference to be held in Geneva, Switzerland.

2010-04-19 12:20:07

Biopsy-based study tilts field toward personalized treatment, more efficient clinical trials.

2010-04-06 07:00:00

SAN DIEGO, April 6 /PRNewswire/ -- Tragara Pharmaceuticals, Inc. today announced the completion of patient enrollment to its APRiCOT-L study, a phase II clinical trial of its oral, once-daily anti-cancer agent, Capoxigem® (apricoxib, TG01), in non-small cell lung cancer (NSCLC).

2010-04-02 11:50:23

Results reported in the April 2nd issue of the journal Cell, a Cell Press publication, reveal a new source for the drug resistance that crops up all too often and quickly in the tumors of cancer patients undergoing therapy.

2010-03-05 09:12:32

Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.

2010-03-03 13:27:15

'Salvage' therapy just as suitable for NSCLC patients over age 70 as for younger patients.

2010-02-22 06:00:00

CAMBRIDGE, Mass., Feb. 22 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva(®) (erlotinib) in patients with non-small cell lung cancer (NSCLC).

2010-02-17 07:36:47

Weighing both magnitude of survival benefit and expense, researchers found that the drug erlotinib, which was found to improve overall survival by 2 months in patients with advanced non-small cell lung cancer, is marginally cost-effective.


Word of the Day
obdormition
  • Sleep; the state or condition of being asleep.
  • The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.
The word 'obdormition' comes from a Latin word meaning "to fall asleep".
Related